Published : Oct-2019
No. of Pages : 43
1.1 List of Tables
1.2 List of Figures
2 Respiratory Syncytial Virus: Executive Summary
2.1 Related Reports
2.2 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources Used and Not Used
3.4.2 Forecast Assumptions and Methods
3.5 Epidemiological Forecast for RSV Hospitalized Population (2018-2028)
3.5.1 Number of Hospitalized Adults with Positive RSV Test
3.5.2 Number of Children Hospitalized for Confirmed RSV
3.6 Epidemiological Forecast for RSV Prophylactic Population (2018-2028)
3.6.1 Number of Preterm Births by Gestational Age
3.6.2 Preterm Infants with CLD
3.6.3 Number of Live Births with Hemodynamically Significant Heart Disease
3.6.4 Diagnosed Prevalent Cases of DMD
3.6.5 Number of Diagnosed Prevalent Cases of SMA
3.6.6 Number of Third Trimester Pregnant Women
3.6.7 Number of Adults Living in Nursing Homes/Long-Term Care Institutions
3.7 Discussion
3.7.1 Epidemiological Forecast Insight
3.7.2 Limitations of Analysis
3.7.3 Strengths of Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer
List of Tables
Table 1: 5GM, Summary of the Prophylactic Population in 2018
Table 2: Risk Factors for Severe RSV
List of Figures
Figure 1: 5GM, Children, Boys and Girls, 0-2 Years Old, Confirmed RSV Hospitalizations, N, 2008 and 2018
Figure 2: 5GM, Rate of Preterm Births (per 1,000 Live Births), 2008-2018
Figure 3: 5GM, Percentage of Adults Living in Long-Term Care, Ages ?55 Years, 2008-2018
Figure 4: 5GM, Sources Used to Forecast the Number of Adults Hospitalized Who Test Positive for RSV, 2018-2028
Figure 5: 5GM, Sources Used to Forecast the Number of Children Hospitalized with Confirmed RSV
Figure 6: 5GM, Sources Used to Forecast the Number of Preterm Births
Figure 7: 5GM, Sources Used to Forecast the Number of Preterm Births with CLD, 2018-2028
Figure 8: 5GM, Sources Used to Forecast the Number of Live Births with Hemodynamically Significant Heart Disease
Figure 9: 5GM, Sources Used to Forecast Diagnosed Prevalent Cases of DMD
Figure 10: 5GM, Sources Used to Forecast the Diagnosed Prevalent Cases of SMA
Figure 11: 5GM, Sources Used to Forecast the Number of Third Trimester Pregnancies
Figure 12: 5GM, Sources Used to Forecast the Number of Adults Living in Long-Term Care
Figure 13: 5GM, Number of Hospitalized Adults with Positive RSV Test, Ages ?60 Years, Men and Women, 2018
Figure 14: 5GM, Number of Children Hospitalized for Confirmed RSV, Ages 0-2 Years, Boys and Girls, 2018
Figure 15: 5GM, Number of Preterm Births by Gestational Age, N, 2018
Figure 16: 5GM, Number of Preterm Infants with CLD, N, 2018-2028
Figure 17: 5GM, Number of Live Births with Hemodynamically Significant Heart Disease, 2018-2028
Figure 18: 5GM, Diagnosed Prevalent Cases of DMD in Boys, Ages 0-2 Years, 2018-2028
Figure 19: 5GM, Diagnosed Prevalent Cases of SMA, Boys and Girls, Ages 0-2 Years, 2018-2028
Figure 20: 5GM, Number of Third Trimester Pregnant Women, N, 2018-2028
Figure 21: 5GM, Number of Adults Living in Long-Term Care Institutions, Ages ?55 Years, N, 2018-2028
